Treatment outcomes for 618 women with gestational trophoblastic tumours following a molar pregnancy at the Charing Cross Hospital, 2000–2009
Open Access
- 11 October 2012
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 107 (11) , 1810-1814
Abstract
Background: Methods: Results: Conclusion:Keywords
This publication has 20 references indexed in Scilit:
- Treatment of Low-Risk Gestational Trophoblastic NeoplasiaJournal of Clinical Oncology, 2011
- Gestational trophoblastic diseaseThe Lancet, 2010
- Weekly methotrexate (50mg/m2) without dose escalation as a primary regimen for low-risk gestational trophoblastic neoplasiaGynecologic Oncology, 2010
- The management and outcome of women with post-hydatidiform mole ‘low-risk’ gestational trophoblastic neoplasia, but hCG levels in excess of 100 000 IU l−1British Journal of Cancer, 2010
- Impact of the revised FIGO/WHO system on the management of patients with gestational trophoblastic neoplasiaGynecologic Oncology, 2009
- Methotrexate for 2000 FIGO low-risk gestational trophoblastic neoplasia patients: efficacy and toxicityAmerican Journal of Obstetrics and Gynecology, 2009
- Gestational Trophoblastic NeoplasiaObstetrics & Gynecology, 2008
- Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel/cisplatin alternating with paclitaxel/etoposide (TP/TE)Annals of Oncology, 2008
- Gestational trophoblastic neoplasia, FIGO 2000 staging and classificationInternational Journal of Gynecology & Obstetrics, 2003
- Effect of Methotrexate Therapy upon Choriocarcinoma and ChorioadenomaExperimental Biology and Medicine, 1956